1. Home
  2. IDYA vs DAC Comparison

IDYA vs DAC Comparison

Compare IDYA & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$28.22

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$129.50

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
DAC
Founded
2015
1972
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
IDYA
DAC
Price
$28.22
$129.50
Analyst Decision
Strong Buy
Buy
Analyst Count
16
2
Target Price
$52.86
$112.50
AVG Volume (30 Days)
676.7K
81.5K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
3.00%
EPS Growth
61.90
N/A
EPS
N/A
N/A
Revenue
$218,710,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$201.05
N/A
P/E Ratio
N/A
$4.01
Revenue Growth
3024.43
N/A
52 Week Low
$20.47
$83.56
52 Week High
$39.28
$135.21

Technical Indicators

Market Signals
Indicator
IDYA
DAC
Relative Strength Index (RSI) 41.29 55.38
Support Level $27.66 $92.03
Resistance Level $29.74 $135.00
Average True Range (ATR) 1.05 3.99
MACD 0.04 -0.84
Stochastic Oscillator 22.94 55.49

Price Performance

Historical Comparison
IDYA
DAC

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: